SB 1064 Oklahoma Senate · 2025 Regular Session

Health insurance; establishing guidelines for step therapy protocol. Effective date,

SB 1064 requires health insurance plans in Oklahoma to use evidence-based clinical guidelines when creating step therapy protocols (which dictate the order of medications covered for a condition). It mandates that insurers provide a clear, accessible process for patients and doctors to request exceptions to these protocols, including a 72-hour response deadline (24 hours for emergencies), with exceptions automatically approved if deadlines are missed. The bill specifies five medical justifications for granting exceptions, such as drug ineffectiveness, adverse reactions, or prior successful use of a medication. This directly affects insurers, healthcare providers, and patients seeking coverage for specific prescription drugs under step therapy.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 3, 2025 Last action Feb 26, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Floor (Senate) · 4 edits
MODERATE
The Senate Floor version of SB 1064 adds new requirements for health insurance plans to respond to step therapy exception requests and appeals within 72 hours (24 hours for urgent cases), with automatic approval if the deadline is missed. It also adds clarifying provisions about pharmaceutical samples and provider prescribing rights.
Scope change
No change to the bill's scope or applicability; the bill still applies to health insurance plans using step therapy protocols in Oklahoma.
REQUIREMENT

New Section D requires health insurance plans to respond to step therapy exception requests or appeals within 72 hours, or 24 hours if exigent circumstances exist, with automatic approval if the deadline is missed.

New Section E clarifies that the bill does not prevent healthcare providers from prescribing medically appropriate prescription drugs.

New Section F prohibits using pharmaceutical samples solely to meet step therapy exception requirements.

New Section G clarifies that the bill does not prevent drug substitution in accordance with current statutes.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
7
Key actions
1
Committee
1
Feb 24, 2025
Upper · Passed
Reported Do Pass as amended Health and Human Services committee; CR filed
upper
Feb 3, 2025
Introduced
First Reading
upper
2 primary · 0 co-sponsors

Sponsors